Lawmakers push DNA privacy after 23andMe bankruptcy
Why it matters: The uncertainty at 23andMe — a household name in at-home DNA testing — has exposed how vulnerable DNA data can be during corporate turmoil. With more than 15 million users, cybersecurity experts fear personal DNA profiles could be sold off like any other asset.
Driving the news: State Reps. Emily Kinkead (D-Allegheny) and Brian Munroe (D-Bucks) plan to introduce the Genetic Materials Privacy and Compensation Act, which would give Pennsylvanians legal rights to control how their DNA is used — and ensure they get paid if it's sold.
Similar legislation has stalled in past years.
What they're saying:"Personal data like DNA should not be treated as a corporate asset that is sold to the highest bidder," Kinkead said.
Zoom in: The bill would establish individual ownership over genetic material, require informed consent before DNA can be shared with or sold to a third party and guarantee compensation if a company profits from a person's data.
Federal protections like HIPAA don't apply to services like 23andMe because users are considered customers, not patients.
Zoom out: California and North Carolina attorneys general have already urged 23andMe consumers to delete their data, though the company insists that data will not be shared with public databases, insurance companies or law enforcement (without a subpoena, search warrant or court order).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
26 minutes ago
- Business Insider
Ukraine's ground drones work like Lego, with soldiers putting parts together to perform different missions
Ukraine is using ground robots"like Lego," putting them together differently to use for different missions, from evacuations to attacks, a Ukrainian robot operator told Business Insider. Oleksandr Yabchanka, head of the robotic systems for Ukraine's Da Vinci Wolves Battalion, told BI that his unit doesn't have different robot types. Instead, they equip and put them together based on specific needs. They might use a rigid capsule so it can carry a wounded soldier, but later, if they need to destroy a Russian position, they attach a bomb to it and "turn that system into a kamikaze one," he said. Yabchanka described ground drones as being adaptable systems that soldiers can put together themselves on the field. "We all remember Lego. We were growing up together with those kits," he said. He also described it as a positive development for Ukraine: In a war where tactics and technology are constantly changing, helping soldiers be nimble could be key. Adaptable robots Vadym Yunyk, the CEO of FRDM Group, which makes the D-21 robotic ground logistics complex, told BI that "the adaptability of the D-21 is one of its key advantages." The robot can be used for transporting provisions like ammunition, as well as for the emergency evacuation of wounded, or even as a platform for mounting weapons. Yunyk said this adaptability means that units can "quickly integrate the platform into their own tactics." The company has also adapted the system further: In response to requests, it attached a combat module to the D-21, making the D-21-12R, a robot that can fire while moving between different positions, Yunyk said. And they're working on adding a grenade launcher, too. "This opens the way to even more flexible applications for the D-21 and D-21-12R," he said. "In other words, we are not just offering a product — we are providing a tool that adapts to the real needs of the front lines." Milrem Robotics, an Estonian company, describes its THeMIS robot, which is being used in Ukraine, as "an advanced multi-role defence platform designed for various operational tasks." The company says its "modular and versatile design allows customization according to the customer's needs" and that its robots can gather intelligence, dispose of ordnance, and evacuate troops. They can also be fitted with a variety of weapons depending on what soldiers have available and want to achieve. Kuldar Väärsi, the founder and CEO of Milrem Robots, told BI that innovation on the battlefield goes even further. He said that soldiers have been using the tech in ways the company wasn't even expecting. "Ukrainian troops are really creative, and they really find very simple ways how to get even more out of the equipment," he said. A new type of warfare Ground robots are not new to warfare, but the scale of their use in Ukraine, the different types of usage, and the number of companies quickly bringing them to the battlefield stand out. They also have the potential to be a key tool for Ukraine, as it has far fewer troops than Russia, which is a much larger country. Russia is also working on its own versions. The speed of innovation is notable, too, with countries rapidly deploying AI and new tech to make them more autonomous and more powerful. Yabchanka said soldiers are playing a key role in that development. He said his troops often tweak, refine, and upgrade the ground robots themselves while on video calls with manufacturers. It's a similar dynamic to the one that drone operators have described to BI. One operator said he often texts and FaceTime manufacturers to give them feedback and get updates. FRDM Group's Yunyk said his robots also have to constantly be updated based on feedback and how soldiers are using them. "The product lifecycle in this war is extremely short," he said. "What worked a month ago may already be outdated today. Therefore, developers do not have the luxury of working according to old templates." He said that if companies spend two years developing a product, "there is a high risk that it will become irrelevant even before development is complete." "This is a new reality in which those who adapt faster, not those who plan longer, win," he added.
Yahoo
2 hours ago
- Yahoo
KLA Corporation Opens $138 Million R&D, Manufacturing Facility in Wales for Semiconductor Innovation
KLA Corporation (NASDAQ:KLAC) is one of the high profit margin stocks to buy now. Towards the end of May, KLA Corporation officially opened a new $138 million R&D and manufacturing facility in Newport, Wales, UK. This investment expands on KLA's existing operations in the region and builds upon decades of semiconductor equipment innovation by SPTS Technologies, which is KLA's Wales-based product division. SPTS has been a key player in semiconductor equipment innovation in Wales since 1984, and has earned multiple Queen's Awards for excellence in R&D and export. KLA acquired SPTS's etch and deposition product lines in 2019. The new 237,000-square-foot Newport facility is designed to meet growing customer demand and strengthen KLA's portfolio. It includes 25,000 square feet of R&D clean rooms and 35,000 square feet of state-of-the-art manufacturing space and tool demo areas. The inner workings of a semiconductor manufacturing facility, neon hued machines humming with activity. The new facility can accommodate 750 employees and is expected to support the electronics ecosystem in Wales, which serves as a center of engineering and manufacturing excellence. KLA's investment strengthens Wales' globally renowned compound semiconductor cluster. The UK Government has also committed ~£5 million to develop the talent pipeline in the sector. KLA Corporation (NASDAQ:KLAC) designs, manufactures, and markets process control, process-enabling, and yield management solutions for the semiconductor and related electronics industries. While we acknowledge the potential of KLAC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
16 hours ago
- Yahoo
Haleon Breaks Ground on new £130m Global Oral Health Innovation Centre
LONDON, July 04, 2025--(BUSINESS WIRE)--This week, Haleon, a global leader in consumer health and maker of leading brands such as Sensodyne, parodontax and Polident, broke ground on its new Global Oral Health Innovation Centre in Weybridge, Surrey. This state-of-the-art facility will enhance Haleon's science capabilities, accelerate innovation, and serve as a centre of excellence for global oral health research. The groundbreaking ceremony, attended by UK Minister Baroness Jones, marks an important step in Haleon's ambition to reach one billion more consumers by 2030, by strengthening its oral health R&D capabilities to put health in more hands globally. Set to become the R&D epicentre for Haleon's oral health portfolio, the centre will be a dynamic hub for pioneering research, product innovation, commercial and supply chain excellence, and cross-functional collaboration. Equipped with the latest technology and global expertise, the centre will feature a cutting-edge digital immersive room designed to unlock value at pace through real-time collaboration with Haleon's manufacturing site in Levice. At the heart of the building, the atrium will create a vibrant hub for teamwork and co-creation, bringing leading expertise together to develop solutions that address unmet oral health needs for consumers around the world. Designed with sustainability at its core, the site has recently achieved a BREEAM® Outstanding rating, recognising its exceptional commitment to sustainability at Phase 1 in the design stage. Franck Riot, Chief R&D Officer, Haleon, said: "We are excited to break ground on our Global Oral Health Innovation Centre - a major investment reflecting our commitment to advancing science and innovation. This powerhouse for oral health research will strengthen Haleon's R&D capabilities and accelerate the development of cutting-edge solutions to meet the evolving oral health needs of consumers around the world." Chancellor of the Exchequer, Rachel Reeves MP, said: "This exciting milestone is another demonstration of the strength of the UK life sciences sector, a key pillar to our Industrial Strategy. Under this government Britain is open for business, and through our Plan for Change we're delivering more investment, more jobs and more money in people's pockets." UK Minister for Technology, Baroness Jones, said: "Haleon is breaking ground on a new centre that will place the UK at the forefront of innovation to improve everyone's oral health - which we know is important to our wider health, and to children's development. This centre, and the substantial investment behind it, is proof that the UK's world-leading life sciences sector is the place to be to grow businesses and work on fresh ideas to transform healthcare. Leveraging these strengths will lead to the long-term economic growth that will help us deliver on our Plan for Change." Jayant Singh, Global Category Lead, Oral Health, Haleon, said: "With oral diseases affecting nearly half the world's population, this marks an exciting step forward in our mission to put health in more hands for millions across the world. This centre will play a key role in harnessing the full potential of science and innovation across our oral health portfolio." About Haleon Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding. View source version on Contacts Media Contacts Philippa +44(0)7969271455 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
